Curis vs Revolution Medicines
CRIS and RVMD side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRIS and RVMD compare
Revolution Medicines is the larger company, worth 32698 times as much as Curis ($41.0B against $1.3M).
Curis scores higher on the StockData Score (7 against 3 for Revolution Medicines), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRIS | RVMD |
|---|---|---|
| Size and price | ||
| Market cap | $1.3M | $41.0B |
| Share price | $0.600 | $191.31 |
| Change, 1 year | −98.0% | 230% |
| Change, 5 years | −100.0% | 468% |
| Beta (5Y) | 2.22 | 1.35 |
| Employees | 24 | 883 |
| StockData Score | ||
| Total score | 7 (better) | 3 |
| Valuation score | 3 (better) | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 0 |
| Health score | 4 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.3× | – |
| P/B | 0.3× (better) | 15.7× |
| FCF yield | – | −3.0% |
| Fair value | $7.07 | – |
| Margin of safety | 91.5% | – |
| Growth | ||
| Revenue growth (TTM) | −62.2% | – |
| Revenue growth, 5Y average | −2.7% | – |
| Profitability | ||
| Operating margin | −203% | – |
| Net margin | −490% | – |
| Return on equity | – | −79.1% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −27.4× |
| Current ratio | 0.49 | 11.38 (better) |
| Altman Z-score | −96.16 | 12.82 (better) |
| Piotroski F-score | 3 (better) | 2 |
| Dividends and buybacks | ||
| Buyback yield | −1961% | – |
| Shareholder yield | −1961% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 32.1% | 105% |
| Held by insiders | 20.4% | 5.3% |
| Insider net buying, 12 months | $5.5K (better) | −$153M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 10.8% | – |
Go deeper
- CRIS stock overview
- CRIS income statement
- CRIS valuation and score
- RVMD stock overview
- RVMD income statement
- RVMD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.